An FDA plan to allow drug companies to distribute reprints of journal articles dealing with off-label drug uses has run into fire from Sen. Charles Grassley (R-IA), Public Citizen and two university professors even as an industry coalition began efforts in April to have the FDA loosen its proposal.
The FDA has a stale and outdated regulatory system for overseeing clinical trial compliance, but several initiatives are under way to modernize it, according to Division of Scientific Investigations director Leslie Ball.
FDA commissioner Andrew von Eschenbach was directed to “stop the buzzwords and toe-dancing” during intense, aggressive questioning by House Energy and Commerce chairman John D. Dingell (D-MI) at an acrimonious Oversight and Investigations Subcommittee hearing on the agency’s inability to prevent the entry of contaminated products.
Three key leaders of the House Energy and Commerce Committee are circulating a discussion draft of their proposed Food and Drug Administration Globalization Act of 2008.
Pfizer’s smoking cessation treatment Chantix was the top-searched prescription brand online in February, generating more than 500,000 search queries, according to internet measurement firm comScor
The long tail of the Internet has been mentioned a few times in this column over the past few years. The long tail actually refers to all the people and businesses near the tail end of the Internet food chain that make money by leveraging what the Internet has to offer, in a million different ways.
Getting your brand noticed early in its lifespan is crucial to pharma product position strategy said, Corinne Le Goff, VP, marketing, at Sanofi-Aventis.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix